Quality assessment of the guidelines for the management of malignant pleural effusions and ascites

Author:

Li Jia-Xi,Shi Yan-Mei,An Li-Ya,Yang Jin-Xu,Qi Yu-Xing,Yang Ting,Cen Yun-Yun,Lin Yue-Ying,Sun Da-LiORCID

Abstract

Abstract Objectives To fully assess the quality of the guidelines for the management of malignant pleural effusions (MPE) and ascites and reveal the heterogeneity of recommendations and possible reasons among guidelines. Methods A systematic search was performed in the database to obtain guidelines for the management of MPE and ascites. The AGREE IIGtool was used to assess the quality of these guidelines. The Measurement Scale of Rate of Agreement (MSRA) was introduced to assess the scientific agreement of formulated recommendations for the management of MPE and ascites among guidelines, and evidence supporting these recommendations was extracted and analyzed. Results Nine guidelines were identified. Only 4 guidelines scored more than 60% and are worth recommending. Recommendations were also heterogeneous among guidelines for the management of MPE, and the main reasons were the different emphases of the recommendations for the treatment of MPE, the contradictions in recommendations, and the unreasonably cited evidence for MPE. Conclusions The quality of the management guidelines for patients with MPE and malignant ascites was highly variable. Specific improvement of the factors leading to the heterogeneity of recommendations will be a reasonable and effective way for developers to upgrade the recommendations in the guidelines for MPE.

Funder

Yunnan health training project of high level talents

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Reference25 articles.

1. Qin SK, Ma J, Li J, Liu XF. Expert consensus on the clinical application of rmhTNF in the treatment of malignant pleural effusion and malignant ascites [J]. Chin Clin Oncol. 2008;23(01):67–72.

2. Bibby AC, Dorn P, Psallidas I, et al. ERS/EACTS statement on the management of malignant pleural effusions. Eur Respir J. 2018;52:1800349.

3. Roberts ME, Neville E, Berrisford RG, et al. Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010. Thorx. 2010;65(Suppl 2):ii32–40.

4. Consensus group of Chinese experts in diagnosis and treatment of malignant pleural effusion. Consensus of experts in diagnosis and treatment of malignant pleural effusion. Chin J Intern Med. 2014;53(3):252–6.

5. Feller-Kopman DJ, Reddy CB, Decamp MM, et al. Management of malignant pleural affusions. An official ATS/STS/STR clinical practice guideline. Am J Respir Crit Care Med. 2018;198(7):839–49.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3